The market share of bacteriostatic water for injection is influenced by several factors, including its use in compounding pharmacies and its role in drug delivery. While specific market share percentages are not readily available, the demand for this sterile water product is linked to the broader pharmaceutical and healthcare sectors.
What is Bacteriostatic Water and Why is it Used?
Bacteriostatic water for injection is sterile water that contains 0.9% benzyl alcohol as a bacteriostatic preservative [1]. This preservative inhibits the growth of bacteria, making the water suitable for use in multi-dose vials and for diluting or dissolving injectable medications [1]. Its primary use is in compounding pharmacies, where medications are custom-prepared for individual patients, and in healthcare settings for administering certain drugs.
What Other Preservatives Are Used in Injectables?
Beyond benzyl alcohol, other preservatives found in injectable formulations include phenol, parabens (methylparaben, propylparaben), and chlorobutanol [2]. The choice of preservative depends on the drug's formulation, its stability, and the intended route of administration.
Who Manufactures Bacteriostatic Water for Injection?
Several pharmaceutical companies produce bacteriostatic water for injection. Brands commonly found include those from Hospira, Fresenius Kabi, and various generic manufacturers [3]. These companies adhere to strict manufacturing standards to ensure the sterility and purity of their products.
When Does Patent Exclusivity Expire for Related Drugs?
The patent exclusivity for drugs that utilize bacteriostatic water for reconstitution or dilution is a critical factor influencing the market. For instance, patents for commonly used injectable drugs will eventually expire, opening the door for generic or biosimilar competition. Information on patent expiry dates for specific drugs can be tracked through resources like DrugPatentWatch.com [4]. This expiry allows for the development and introduction of more affordable alternatives, which can indirectly affect the demand for associated sterile diluents.
How Do Generic Medications Impact the Demand for Diluents?
The introduction of generic versions of injectable medications can increase the overall volume of drug product being prepared and administered. As more generic options become available and are prescribed, the demand for diluents like bacteriostatic water may rise, assuming these generics are formulated for reconstitution with such solutions.
What are the Concerns Regarding Preservatives in Injectables?
While preservatives like benzyl alcohol are essential for maintaining the sterility of multi-dose injectable products, there are patient and clinician concerns. In premature infants, particularly those with low birth weight, the administration of benzyl alcohol has been associated with a condition called gasping syndrome, characterized by metabolic acidosis, respiratory distress, and circulatory collapse [5]. For this reason, benzyl alcohol-free formulations are often preferred or required for neonates. This has led to the development and availability of preservative-free sterile water for injection.